Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Amortization of Deferred Charges (2022 - 2025)

Historic Amortization of Deferred Charges for Gossamer Bio (GOSS) over the last 4 years, with Q3 2025 value amounting to $248000.0.

  • Gossamer Bio's Amortization of Deferred Charges rose 598.29% to $248000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $972000.0, marking a year-over-year decrease of 1591.7%. This contributed to the annual value of $1.1 million for FY2024, which is 1778.96% down from last year.
  • Per Gossamer Bio's latest filing, its Amortization of Deferred Charges stood at $248000.0 for Q3 2025, which was up 598.29% from $245000.0 recorded in Q2 2025.
  • Gossamer Bio's 5-year Amortization of Deferred Charges high stood at $352000.0 for Q1 2023, and its period low was $234000.0 during Q3 2024.
  • Over the past 4 years, Gossamer Bio's median Amortization of Deferred Charges value was $293000.0 (recorded in 2024), while the average stood at $286933.3.
  • Per our database at Business Quant, Gossamer Bio's Amortization of Deferred Charges surged by 2054.79% in 2023 and then crashed by 2755.42% in 2024.
  • Quarter analysis of 4 years shows Gossamer Bio's Amortization of Deferred Charges stood at $270000.0 in 2022, then increased by 14.07% to $308000.0 in 2023, then dropped by 22.73% to $238000.0 in 2024, then rose by 4.2% to $248000.0 in 2025.
  • Its Amortization of Deferred Charges was $248000.0 in Q3 2025, compared to $245000.0 in Q2 2025 and $241000.0 in Q1 2025.